Clinical trial Recruiting at 1 site Interventional Ages 10 to 18

Guided Written Exposure Therapy for Adolescents with Complex PTSD

Official title: The Effectiveness of Guided Written Exposure Therapy for Complex PTSD in Adolescents: A Multicenter Randomized Controlled Trial

Run by Peking University · NCT07325734 · Data updated 2026-11-12

This study will test whether group Guided Written Exposure Therapy helps Chinese adolescents (ages 10–18) with complex PTSD feel better than supportive group therapy.

Quick facts

Study typeInterventional
Ages10 Years to 18 Years
SexAll
Enrollment130 (estimated)
SponsorPeking University
Academic / other
Locations4 sites (Fuyang, Anhui and 3 other locations)
StatusRecruiting
StartedOctober 10, 2025
Main results expectedNovember 25, 2026
Study endsDecember 25, 2026
Registry record updatedSeptember 2, 2026
Trial IDNCT07325734 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are literate adolescents aged 10–18 with diagnosed or subclinical complex PTSD who can attend group sessions and provide (or whose guardians provide) written consent.

Probably not a fit

Patients with severe psychiatric or neurodevelopmental disorders, serious physical illness, high suicide risk, or inability to complete writing tasks are unlikely to benefit or be eligible.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This randomized controlled trial will enroll 120 Chinese adolescents with complex PTSD and randomly assign 60 to group Guided Written Exposure Therapy for CPTSD (GWE-C) and 60 to supportive group therapy. The GWE-C intervention consists of 7 to 10 group writing-and-discussion sessions that focus on trauma-related narratives. The primary outcome, measured by the International Trauma Questionnaire (ITQ), will be collected at baseline, post-treatment, 1-month follow-up, and 3-month follow-up. The trial will be conducted at Peking University in Beijing and a partnering middle school site in Fuyang, Anhui.

Why it matters

Potential benefit: If successful, the intervention could offer an effective, low-cost group therapy option that reduces CPTSD symptoms in adolescents.

How similar studies have gone: Written exposure therapies have shown benefit for PTSD in adults and some adolescent work exists, but group guided written exposure specifically for adolescent complex PTSD is relatively novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

1. Aged between 10 and 18 years;
2. Meet the diagnostic or subclinical criteria for Complex PTSD (C-PTSD), defined as missing at most one symptom from either the PTSD or DSO clusters;
3. Possess sufficient literacy and language skills to complete writing-based tasks;
4. Be able to understand the study procedures and complete the required assessments;
5. Provide written informed consent, with consent also obtained from their legal guardians.

Exclusion Criteria:

1. Presence of a severe psychiatric disorder or neurodevelopmental disorder, such as schizophrenia, bipolar I disorder, autism spectrum disorder, intellectual disability, or other severe psychiatric conditions that would interfere with study participation;
2. Presence of a severe physical illness that would impair the ability to engage in the intervention;
3. Assessed as being at high suicidal risk (e.g., current suicidal ideation with intent or plan, recent suicide attempt within the past 12 months, or severe self-harm behaviors);
4. Ongoing exposure to traumatic events;
5. Currently receiving other trauma-focused psychological treatments.

Where it's running

  • Peking University
    Beijing, Beijing Municipality, China
    Recruiting
  • Changchun middle school
    Fuyang, Anhui, China
    Completed
  • Ulanhot No. 1 High School
    Ulanhot, Inner Mongolia, China
    Completed
  • Urumqi No. 74 Middle School
    Ürümqi, Xinjiang, China
    Completed

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.